<?xml version="1.0" encoding="UTF-8"?>
<p>In one investigation, by expressing the structural proteins of MERS-CoV in silkworm larvae and Bm5 cells, some vaccine candidates were prepared. Consequently, the spike S protein of MERS-CoV came up short on its transmembrane, and the cytoplasmic areas (SΔTM) were discharged into the hemolymph of silkworm larvae utilizing a bombyxin signal peptide and refined by applying affinity chromatography. The purified SΔTM generated small NPs as well as the full-length S protein and displayed the capability of binding to human dipeptidyl peptidase 4 (a receptor of MERS-CoV) [
 <xref rid="B126-nanomaterials-10-01072" ref-type="bibr">126</xref>], thus revealing that bioactive SΔTM could express in silkworm larvae. For the production of MERS-CoV-like particles, the co-expression of spike proteins has been completed in Bm5 cells, and envelope (E) and membrane (M) proteins secreted E and M proteins extracellularly, signifying that MERS-CoV-LPs might be generated. Although S protein has not been detected on virus-like particles (VLPs), E and M proteins have been located in the culture supernatant; S protein-displaying nanovesicles (~100–200 nm) were formed and confirmed by immuno-transmission electron microscopy (TEM). These purified SΔTM can be deployed to produce innovative NP-based vaccines against CoVs and in diagnostic detecting approaches [
 <xref rid="B126-nanomaterials-10-01072" ref-type="bibr">126</xref>].
</p>
